UNSPSC 51432006: Delapril hydrochloride

This classification denotes an ace inhibitor with the molecular formula C26H32N2O5.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2SMM3M5ZMH, chemically known as glycine, n-(2,3-dihydro-1h-inden-2-yl)-n-(n-(1-(ethoxycarbonyl)-3-phenylpropyl)-l-alanyl)-, monohydrochloride, (s)- but more generally known as delapril hydrochloride, which bears US NIH Compound Identifier 5362115. European Medicines Agency schedules Delapril hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01574MIG.

UNSPSC 51432006 Delapril hydrochloride is a Commodity-tier code that captures individual pharmaceutical active ingredients and formulations procured by state and local health systems, fire rescue services, and pharmacy benefit programs. Recent state and local solicitations under this code reflect demand for specific branded or generic medications supplied to emergency medical services, institutional healthcare facilities, and state pharmacy networks. The issuing bodies include municipal fire departments (Tampa Fire Rescue via City of Tampa), state health and human services commissions (Texas HHS), and multistate cooperative purchasing alliances serving state agencies and local government members (Minnesota Multistate Cooperative Purchasing Alliance). The scope of work spans both direct procurement of finished pharmaceutical products with specified unit quantities and expiration windows, and vendor capacity assessment for direct-to-manufacturer contracting models intended to bypass traditional pharmacy benefit managers and wholesalers.

Activity under this code concentrates in Florida, Texas, and Minnesota based on recent solicitation volume. The City of Tampa issued an Invitation for Bid (IFB) No. 26P00188 for Advanced Life Support Medications on April 24, 2026, with a response deadline of April 8, 2026, seeking 370 units of Labetalol HCI 100mg vials, 1,810 units of Epinephrine 1:10,000 injections, 330 units of Adenosine 6mg vials, and 1,020 units of Diltiazem 25mg vials for Tampa Fire Rescue, with an estimated contract value of $40,000 and a Small Local Business Enterprise sheltered-market designation offering a 5 percent bid discount. The Texas Health and Human Services Commission issued Request for Information No. HHS0017013 on April 3, 2026, seeking vendor capabilities for direct-to-manufacturer prescription fulfillment models outside traditional PBM and wholesaler channels. The Minnesota Department of Administration's Office of State Procurement, administering MMCAP, issued an RFP for generic multi-source pharmaceuticals and OTC products with a response deadline of March 26, 2026, requiring products to be available by May 15, 2026, and effective July 1, 2026, with evaluation weighted 75 percent on price competitiveness and 25 percent on compliance, EDI capability, and administrative requirements.